Evidence map›Paper›PMID 42015505›Full record

ArticleNursing open2026

Global Economic Evaluation of the Nurse Prescribing of Medication Role: A Scoping Review.

Francisco Javier Gomis-Jimeno, Mojtaba Vaismoradi, Manuel Lillo-Crespo

Abstract readScoping Review
In one paragraph

Article in Nursing open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francisco Javier Gomis-JimenoDepartment of Nursing, Faculty of Health Sciences, University of Alicante, Alicante, Spain.ORCID https://orcid.org/0000-0003-3939-4150
Mojtaba VaismoradiFaculty of Nursing and Health Sciences, Nord University, Bodø, Norway.ORCID https://orcid.org/0000-0002-5157-4886
Manuel Lillo-CrespoDepartment of Nursing, Faculty of Health Sciences, University of Alicante, Alicante, Spain.ORCID https://orcid.org/0000-0003-2053-2808

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a paucity of evidence and reports addressing the Economic Evaluation in Health (EEH) of the implementation of the Nurse Prescribing of Medication (NPM) role. Consequently, there is limited knowledge about the economic costs and the overall impact of NPM on healthcare systems worldwide where it has been implemented. This gap of knowledge limits the ability of other nations to determine whether adopting this initiative would be beneficial. A few countries have published their NPM economic benefits, though available scientific publications have focused on NPM clinical effectiveness, particularly regarding quality and safety in patient care.

objectiveThis review aimed at mapping the current knowledge about the role played by the NPM internationally in terms of EEH in terms of direct and indirect economic benefits for cost minimization, cost-effectiveness, cost-utility, cost-benefit, return on investment and healthcare cost savings.

designA scoping review of international literature was conducted based on the PRISMA-ScR checklist and the Johanna Briggs Institute Guide to identify scientific evidence and relevant grey literature on the review topic.

methodsThe search strategy was conducted in four bibliographic databases of Scopus, Web of Science, PubMed (covering Medline) and Google Scholar, with no time restrictions, covering publications up to 30 September 2024. The search was performed in both English and Spanish, selecting relevant publications based on inclusion and exclusion criteria. For research synthesis and data analysis, two summaries were developed: one summarizing the findings from the scientific literature search and the other summarizing the results from the grey literature search.

resultsThe 26 included studies in this scoping review suggest a positive EEH across various countries where its implementation has led to enhanced efficiency, reduced healthcare costs and improved economic profitability. The actions carried out for decades in those countries represent a significant reduction in direct and indirect costs, also in medical supplies and waiting lists, as well as an increase in the quality of patient care leading to a positive contribution to healthcare systems' sustainability.

conclusionsImproving the conditions and utilization of NPM is essential to maximize nurses' contribution to patient care within healthcare systems. More high-quality research is required to identify and examine economic effectiveness and healthcare cost savings by governments and other healthcare organizations, given that evidence regarding the benefits of the NPM role globally is insufficient.

Indexed as

Cost-Benefit AnalysisDrug PrescriptionsNurse's RoleCost-Effectiveness AnalysisHumansNon-Medical Prescribinghealth economic evaluationnon‐medical prescribingnurse prescribingpatient safetyscoping review

Identifiers

PMID42015505
PMCPMC13100307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.